The most common adverse event is moderate to severe [[rash]], which occurs in up to 20% of patients.<ref>[http://www.pfizer.com/pfizer/download/uspi_rescriptor.pdf RESCRIPTOR brand of delavirdine mesylate tablets. Product information.]</ref> Other common adverse events include [[fatigue (physical)|fatigue]], [[headache]] and [[nausea]]. Liver toxicity has also been reported.
